NCT02079740 2025-09-30Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid TumorsNational Cancer Institute (NCI)Phase 1/2 Active not recruiting96 enrolled 30 charts
NCT02070549 2025-02-13Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionNational Cancer Institute (NCI)Phase 1 Completed46 enrolled